vs
ASPEN AEROGELS INC(ASPN)与PUMA BIOTECHNOLOGY, INC.(PBYI)财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ASPEN AEROGELS INC的1.8倍($75.5M vs $41.3M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs -66.4%),PUMA BIOTECHNOLOGY, INC.自由现金流更多($14.4M vs $13.7M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs -33.9%)
Aspen Aerogels Inc是全球领先的气凝胶基高性能隔热及热管理材料生产商,产品广泛应用于可再生能源、油气基础设施、航空航天、商业建筑与工业制造领域,核心市场覆盖北美、欧洲及亚太地区,旗下材料以优异的耐热性、防火性能和轻量化特性广受客户认可。
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
ASPN vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$41.3M
营收增速更快
PBYI
高出94.1%
-66.4%
自由现金流更多
PBYI
多$712.0K
$13.7M
两年增速更快
PBYI
近两年复合增速
-33.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $41.3M | $75.5M |
| 净利润 | $-72.9M | — |
| 毛利率 | -55.5% | 69.3% |
| 营业利润率 | -170.3% | 22.7% |
| 净利率 | -176.4% | — |
| 营收同比 | -66.4% | 27.7% |
| 净利润同比 | -741.7% | — |
| 每股收益(稀释后) | $-0.87 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASPN
PBYI
| Q4 25 | $41.3M | $75.5M | ||
| Q3 25 | $73.0M | $54.5M | ||
| Q2 25 | $78.0M | $52.4M | ||
| Q1 25 | $78.7M | $46.0M | ||
| Q4 24 | $123.1M | $59.1M | ||
| Q3 24 | $117.3M | $80.5M | ||
| Q2 24 | $117.8M | $47.1M | ||
| Q1 24 | $94.5M | $43.8M |
净利润
ASPN
PBYI
| Q4 25 | $-72.9M | — | ||
| Q3 25 | $-6.3M | $8.8M | ||
| Q2 25 | $-9.1M | $5.9M | ||
| Q1 25 | $-301.2M | $3.0M | ||
| Q4 24 | $11.4M | — | ||
| Q3 24 | $-13.0M | $20.3M | ||
| Q2 24 | $16.8M | $-4.5M | ||
| Q1 24 | $-1.8M | $-4.8M |
毛利率
ASPN
PBYI
| Q4 25 | -55.5% | 69.3% | ||
| Q3 25 | 28.5% | 77.7% | ||
| Q2 25 | 32.4% | 76.5% | ||
| Q1 25 | 29.0% | 77.1% | ||
| Q4 24 | 38.3% | 76.4% | ||
| Q3 24 | 41.8% | 63.9% | ||
| Q2 24 | 43.8% | 77.4% | ||
| Q1 24 | 37.2% | 75.5% |
营业利润率
ASPN
PBYI
| Q4 25 | -170.3% | 22.7% | ||
| Q3 25 | -4.6% | 17.6% | ||
| Q2 25 | -6.6% | 12.7% | ||
| Q1 25 | -380.2% | 8.7% | ||
| Q4 24 | 12.0% | 22.6% | ||
| Q3 24 | 14.8% | 27.4% | ||
| Q2 24 | 17.0% | -4.6% | ||
| Q1 24 | 2.6% | -5.3% |
净利率
ASPN
PBYI
| Q4 25 | -176.4% | — | ||
| Q3 25 | -8.7% | 16.2% | ||
| Q2 25 | -11.6% | 11.2% | ||
| Q1 25 | -382.7% | 6.5% | ||
| Q4 24 | 9.2% | — | ||
| Q3 24 | -11.1% | 25.2% | ||
| Q2 24 | 14.3% | -9.6% | ||
| Q1 24 | -1.9% | -11.0% |
每股收益(稀释后)
ASPN
PBYI
| Q4 25 | $-0.87 | $0.26 | ||
| Q3 25 | $-0.08 | $0.17 | ||
| Q2 25 | $-0.11 | $0.12 | ||
| Q1 25 | $-3.67 | $0.06 | ||
| Q4 24 | $0.15 | $0.40 | ||
| Q3 24 | $-0.17 | $0.41 | ||
| Q2 24 | $0.21 | $-0.09 | ||
| Q1 24 | $-0.02 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $156.9M | $97.5M |
| 总债务越低越好 | $65.5M | $22.7M |
| 股东权益账面价值 | $235.5M | $130.3M |
| 总资产 | $406.7M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.28× | 0.17× |
8季度趋势,按日历期对齐
现金及短期投资
ASPN
PBYI
| Q4 25 | $156.9M | $97.5M | ||
| Q3 25 | $150.7M | $94.4M | ||
| Q2 25 | $167.6M | $96.0M | ||
| Q1 25 | $192.0M | $93.2M | ||
| Q4 24 | $220.9M | $101.0M | ||
| Q3 24 | $113.5M | $96.7M | ||
| Q2 24 | $91.4M | $96.8M | ||
| Q1 24 | $101.5M | $107.2M |
总债务
ASPN
PBYI
| Q4 25 | $65.5M | $22.7M | ||
| Q3 25 | $70.1M | $34.0M | ||
| Q2 25 | $77.3M | $45.3M | ||
| Q1 25 | $95.4M | $56.7M | ||
| Q4 24 | $95.0M | $68.0M | ||
| Q3 24 | $93.7M | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益
ASPN
PBYI
| Q4 25 | $235.5M | $130.3M | ||
| Q3 25 | $305.7M | $115.3M | ||
| Q2 25 | $308.8M | $104.7M | ||
| Q1 25 | $314.8M | $97.1M | ||
| Q4 24 | $614.7M | $92.1M | ||
| Q3 24 | $507.6M | $71.1M | ||
| Q2 24 | $517.8M | $48.5M | ||
| Q1 24 | $491.2M | $51.0M |
总资产
ASPN
PBYI
| Q4 25 | $406.7M | $216.3M | ||
| Q3 25 | $491.4M | $202.9M | ||
| Q2 25 | $525.1M | $194.9M | ||
| Q1 25 | $555.0M | $196.2M | ||
| Q4 24 | $895.1M | $213.3M | ||
| Q3 24 | $782.6M | $220.7M | ||
| Q2 24 | $748.6M | $205.0M | ||
| Q1 24 | $698.0M | $214.1M |
负债/权益比
ASPN
PBYI
| Q4 25 | 0.28× | 0.17× | ||
| Q3 25 | 0.23× | 0.30× | ||
| Q2 25 | 0.25× | 0.43× | ||
| Q1 25 | 0.30× | 0.58× | ||
| Q4 24 | 0.15× | 0.74× | ||
| Q3 24 | 0.18× | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $16.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $13.7M | $14.4M |
| 自由现金流率自由现金流/营收 | 33.1% | 19.1% |
| 资本支出强度资本支出/营收 | 6.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-4.6M | $41.7M |
8季度趋势,按日历期对齐
经营现金流
ASPN
PBYI
| Q4 25 | $16.1M | $14.4M | ||
| Q3 25 | $15.0M | $9.7M | ||
| Q2 25 | $-3.9M | $14.1M | ||
| Q1 25 | $5.6M | $3.6M | ||
| Q4 24 | $35.7M | $15.6M | ||
| Q3 24 | $20.8M | $11.0M | ||
| Q2 24 | $6.8M | $1.0M | ||
| Q1 24 | $-17.7M | $11.2M |
自由现金流
ASPN
PBYI
| Q4 25 | $13.7M | $14.4M | ||
| Q3 25 | $5.9M | $9.7M | ||
| Q2 25 | $-16.8M | $14.1M | ||
| Q1 25 | $-7.4M | $3.6M | ||
| Q4 24 | $20.9M | $15.6M | ||
| Q3 24 | $-50.0K | $11.0M | ||
| Q2 24 | $-18.0M | $1.0M | ||
| Q1 24 | $-43.6M | — |
自由现金流率
ASPN
PBYI
| Q4 25 | 33.1% | 19.1% | ||
| Q3 25 | 8.1% | 17.7% | ||
| Q2 25 | -21.6% | 26.8% | ||
| Q1 25 | -9.4% | 7.7% | ||
| Q4 24 | 17.0% | 26.4% | ||
| Q3 24 | -0.0% | 13.7% | ||
| Q2 24 | -15.3% | 2.1% | ||
| Q1 24 | -46.1% | — |
资本支出强度
ASPN
PBYI
| Q4 25 | 6.0% | 0.0% | ||
| Q3 25 | 12.5% | 0.0% | ||
| Q2 25 | 16.5% | 0.0% | ||
| Q1 25 | 16.5% | 0.1% | ||
| Q4 24 | 12.0% | 0.0% | ||
| Q3 24 | 17.7% | 0.0% | ||
| Q2 24 | 21.1% | 0.0% | ||
| Q1 24 | 27.4% | 0.0% |
现金转化率
ASPN
PBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 3.14× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPN
| Energy Industrial | $14.5M | 35% |
| Other | $13.9M | 34% |
| Thermal Barrier | $12.9M | 31% |
PBYI
暂无分部数据